{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:52:13Z","timestamp":1782485533301,"version":"3.54.5"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clinimag.2024.110334","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T11:47:22Z","timestamp":1729511242000},"page":"110334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ethical principles for practice building in the era of targeted radioligand therapy"],"prefix":"10.1016","volume":"116","author":[{"given":"Jacob A.","family":"Blythe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.C.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clinimag.2024.110334_bb0005","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41571-022-00652-y","article-title":"Radiotheranostics in oncology: current challenges and emerging opportunities","volume":"19","author":"Bodei","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"10.1016\/j.clinimag.2024.110334_bb0010","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(22)00605-2","article-title":"PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [(177)Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial","volume":"23","author":"Buteau","year":"2022","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clinimag.2024.110334_bb0015","article-title":"The molecular effects of ionizing radiations on brain cells: radiation necrosis vs","volume":"9","author":"Cuccurullo","year":"2019","journal-title":"Tumor Recurrence Diagnostics (Basel)"},{"issue":"6","key":"10.1016\/j.clinimag.2024.110334_bb0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2967\/jnumed.122.264144","article-title":"How many Theranostics centers will we need in the United States?","volume":"63","author":"Czernin","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2024.110334_bb0025","series-title":"Just Health: Meeting Health Needs Fairly","author":"Daniels","year":"2007"},{"key":"10.1016\/j.clinimag.2024.110334_bb0030","article-title":"Implementation of basic life support education for the lay public in China: barriers, enablers, and possible solutions. Frontiers","volume":"12","author":"Dong","year":"2024","journal-title":"Public Health"},{"issue":"8","key":"10.1016\/j.clinimag.2024.110334_bb0035","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00259-020-05102-4","article-title":"(177)Lu-PSMA for advanced prostate cancer: are we ready to play big?","volume":"48","author":"Hehakaya","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.clinimag.2024.110334_bb0040","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s00259-022-05785-x","article-title":"Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics Centre","volume":"49","author":"Herrmann","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clinimag.2024.110334_bb0045","first-page":"3","article-title":"Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry. Frontiers","author":"Meyer","year":"2023","journal-title":"Nuclear Medicine"},{"issue":"6","key":"10.1016\/j.clinimag.2024.110334_bb0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacr.2004.02.007","article-title":"Patient radiation ID cards","volume":"1","author":"Morin","year":"2004","journal-title":"J Am Coll Radiol"},{"issue":"3","key":"10.1016\/j.clinimag.2024.110334_bb0055","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2967\/jnumed.122.265194","article-title":"Clinical implementation of (177)Lu-PSMA-617 in the United States: lessons learned and ongoing challenges","volume":"64","author":"Ravi","year":"2023","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.clinimag.2024.110334_bb0060","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177\u2013PSMA-617 for metastatic castration-resistant prostate Cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089970712400264X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089970712400264X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:41:09Z","timestamp":1782484869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089970712400264X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":12,"alternative-id":["S089970712400264X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2024.110334","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethical principles for practice building in the era of targeted radioligand therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2024.110334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110334"}}